Novartis Ag (DE:NOTA)

FRANKFURT:NOTA

NOTA

Novartis

RESEARCH TOOLSreports

Compare Novartis (NOTA) vs. Competitors

23 Followers

Comparison Results

NOTA

Novartis

€132.00

€240.10B

19.02

43.48%

3 Buy

3 Hold

0 Sell

Moderate Buy

Merck & Company

$121.42

$300.20B

14.46

56.57%

13 Buy

7 Hold

0 Sell

Moderate Buy

Pfizer

$26.92

$153.13B

18.21

24.69%

8 Buy

13 Hold

2 Sell

Moderate Buy

Sanofi

$46.76

$112.83B

―

-5.84%

1 Buy

1 Hold

0 Sell

Moderate Buy

AbbVie

$207.94

$367.80B

96.82

19.37%

14 Buy

7 Hold

0 Sell

Moderate Buy

AstraZeneca

15230.00 p

£236.19B

28.13

52.03%

13 Buy

2 Hold

1 Sell

Strong Buy

xxxxxxxxxxxxx

NOTA vs AZN

xxxxxxxxxxxxx

Performance Comparison

DE:NOTA

Novartis

132.00

37.46

39.62%

MRK

Merck & Company

121.42

45.03

58.94%

PFE

Pfizer

26.92

6.30

30.53%

SNY

Sanofi

46.76

-3.48

-6.92%

ABBV

AbbVie

207.94

34.65

20.00%

GB:AZN

AstraZeneca

15,230.00

5,086.78

50.15%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >